Literature DB >> 28844477

Rigging Innate Immunity against the Flu.

Arthur M Krieg1.   

Abstract

Mesh：

Year:  2017        PMID： 28844477      PMCID： PMC5589152          DOI： 10.1016/j.ymthe.2017.08.008

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  11 in total

Review 1.  Inhaled innate immune ligands to prevent pneumonia.

Authors:  Scott E Evans; Michael J Tuvim; Cory J Fox; Nidhi Sachdev; Leonid Gibiansky; Burton F Dickey
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

2.  The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo.

Authors:  Silvia Bellocchio; Claudia Montagnoli; Silvia Bozza; Roberta Gaziano; Giordano Rossi; Salamatu S Mambula; Annunciata Vecchi; Alberto Mantovani; Stuart M Levitz; Luigina Romani
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

3.  TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells.

Authors:  Urvashi Bhan; Nicholas W Lukacs; John J Osterholzer; Michael W Newstead; Xianying Zeng; Thomas A Moore; Tracy R McMillan; Arthur M Krieg; Shizuo Akira; Theodore J Standiford
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

4.  RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection.

Authors:  Christoph Coch; Jan Phillip Stümpel; Vanessa Lilien-Waldau; Dirk Wohlleber; Beate M Kümmerer; Isabelle Bekeredjian-Ding; Georg Kochs; Natalio Garbi; Stephan Herberhold; Christine Schuberth-Wagner; Janos Ludwig; Winfried Barchet; Martin Schlee; Achim Hoerauf; Friedrich Bootz; Peter Staeheli; Gunther Hartmann; Evelyn Hartmann
Journal:  Mol Ther       Date:  2017-07-08       Impact factor: 11.454

Review 5.  Antiinfective applications of toll-like receptor 9 agonists.

Authors:  Arthur M Krieg
Journal:  Proc Am Thorac Soc       Date:  2007-07

Review 6.  Standing on three legs: antiviral activities of RIG-I against influenza viruses.

Authors:  Michaela Weber-Gerlach; Friedemann Weber
Journal:  Curr Opin Immunol       Date:  2016-06-16       Impact factor: 7.486

Review 7.  RIG-I in RNA virus recognition.

Authors:  Alison M Kell; Michael Gale
Journal:  Virology       Date:  2015-03-05       Impact factor: 3.616

8.  Nucleic Acid Immunity.

Authors:  G Hartmann
Journal:  Adv Immunol       Date:  2016-12-15       Impact factor: 3.543

9.  Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity.

Authors:  Marie-Line Goulet; David Olagnier; Zhengyun Xu; Suzanne Paz; S Mehdi Belgnaoui; Erin I Lafferty; Valérie Janelle; Meztli Arguello; Marilene Paquet; Khader Ghneim; Stephanie Richards; Andrew Smith; Peter Wilkinson; Mark Cameron; Ulrich Kalinke; Salman Qureshi; Alain Lamarre; Elias K Haddad; Rafick Pierre Sekaly; Suraj Peri; Siddharth Balachandran; Rongtuan Lin; John Hiscott
Journal:  PLoS Pathog       Date:  2013-04-25       Impact factor: 6.823

10.  Defining the functional determinants for RNA surveillance by RIG-I.

Authors:  Andrew Kohlway; Dahai Luo; David C Rawling; Steve C Ding; Anna Marie Pyle
Journal:  EMBO Rep       Date:  2013-07-30       Impact factor: 8.807
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.